We have partnered with AI|ffinity and are pleased to announce the availability of deepHitExplorer.
We have started offering deepHitExplorer, an AI-assisted platform developed by AI|ffinity, a lab-in-the-loop venture company originating from the Czech Republic.
deepHitExplorer combines ligand epitope-aware AI and diversity selection algorithms to accelerate hit discovery, providing practical AI-assisted support for early-stage drug discovery.
For more information about deepHitExplorer, including its features and system requirements, please visit the product page below.